IM Cannabis

IM Cannabis Corp. is an international medical cannabis company based in Tel Aviv, Israel, founded in 2010 by Oren Shuster and Rafael Gabay. The company specializes in the breeding, cultivation, and distribution of medical cannabis products, primarily serving patients in Israel and Germany. Its product offerings include various strains and oils, as well as research and development of new genetic strains. IM Cannabis also provides intellectual property services related to the medical cannabis industry. The majority of its revenue is derived from sales in Israel, with additional income generated from its operations in Germany.

Uri Birenberg

CFO, Finance

3 past transactions

Oranim Pharm

Acquisition in 2022
Oranim Pharm is one of the largest pharmacies specializing in medical cannabis in Israel. It operates a network of pharmacies primarily in Jerusalem, offering a diverse range of products that include medical cannabis, fertility drugs, over-the-counter medications, nutritional supplements, vitamins, body care items, toiletries, and oral health products. This extensive selection enables individuals to access a variety of medicines and health-related items conveniently.

MYM Nutraceuticals

Acquisition in 2021
MYM Nutraceuticals Inc. is a Canadian company engaged in the cultivation, processing, and distribution of cannabis products. Established in 2014 and headquartered in Vancouver, the company focuses on acquiring Health Canada licenses to produce and market high-quality organic medicinal cannabis supplements and topical products. MYM operates two large-scale production projects in Québec, which, upon completion, will provide over 1.5 million square feet of production space. The company is also involved in various stages of the cannabis supply chain, including retail, processing, and product infusion, emphasizing the use of cannabis for healthcare purposes.

Trichome Financial

Acquisition in 2020
Trichome is a specialty finance company focused on providing flexible and creative capital solutions to the global legal cannabis market. Trichome was created to address the lack of credit availability in the large, growing and increasingly complex cannabis market. Founded by industry leaders Origin House and Stoic Advisory, Trichome's experienced management team has a unique edge to capitalize on proprietary deal flow and industry insight while developing a first mover advantage as a global cannabis-focused specialty finance company. Trichome provides customized financing solutions across the industry value chain to support growth, capital expenditures, mergers, acquisitions, working capital and other needs. Leveraging the combined resources and knowledge of its founders, it is able to offer significant value-added financial, product, market and operational support to its partner companies. Trichome's current assets are all based in Canada and it has no operations or assets in the United States.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.